Samuel Wilks

1.9k total citations
12 papers, 381 citations indexed

About

Samuel Wilks is a scholar working on Infectious Diseases, Epidemiology and Animal Science and Zoology. According to data from OpenAlex, Samuel Wilks has authored 12 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Epidemiology and 4 papers in Animal Science and Zoology. Recurrent topics in Samuel Wilks's work include Influenza Virus Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Respiratory viral infections research (4 papers). Samuel Wilks is often cited by papers focused on Influenza Virus Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Respiratory viral infections research (4 papers). Samuel Wilks collaborates with scholars based in United Kingdom, Netherlands and Austria. Samuel Wilks's co-authors include Derek J. Smith, Ron A. M. Fouchier, Guus F. Rimmelzwaan, Gerrie de Mutsert, Albert D. M. E. Osterhaus, Marion Koopmans, Fiona van der Klis, Rogier Bodewes, Mariangela Ventresca and David F. Burke and has published in prestigious journals such as Nature, Nature Communications and The Journal of Infectious Diseases.

In The Last Decade

Samuel Wilks

12 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Wilks United Kingdom 7 232 155 113 77 39 12 381
Colleen Furey United States 7 177 0.8× 150 1.0× 83 0.7× 132 1.7× 33 0.8× 7 335
Monique Ambrose United States 3 247 1.1× 101 0.7× 98 0.9× 45 0.6× 11 0.3× 3 337
Kangchon Kim United States 5 421 1.8× 171 1.1× 108 1.0× 110 1.4× 19 0.5× 5 484
Malet Aban Australia 7 194 0.8× 109 0.7× 70 0.6× 32 0.4× 19 0.5× 10 271
Svetlana Donina Russia 14 386 1.7× 157 1.0× 159 1.4× 51 0.7× 23 0.6× 34 442
Myeisha Paskel United States 11 402 1.7× 177 1.1× 121 1.1× 59 0.8× 40 1.0× 15 462
Matthew Edmans United Kingdom 10 159 0.7× 117 0.8× 108 1.0× 52 0.7× 55 1.4× 12 290
Wu-Tse Liu Taiwan 7 85 0.4× 271 1.7× 55 0.5× 68 0.9× 49 1.3× 9 389
Shahjahan Miah United Kingdom 10 266 1.1× 142 0.9× 52 0.5× 83 1.1× 12 0.3× 16 392
Nazia Thakur United Kingdom 11 95 0.4× 213 1.4× 41 0.4× 48 0.6× 53 1.4× 18 288

Countries citing papers authored by Samuel Wilks

Since Specialization
Citations

This map shows the geographic impact of Samuel Wilks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Wilks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Wilks more than expected).

Fields of papers citing papers by Samuel Wilks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Wilks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Wilks. The network helps show where Samuel Wilks may publish in the future.

Co-authorship network of co-authors of Samuel Wilks

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Wilks. A scholar is included among the top collaborators of Samuel Wilks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Wilks. Samuel Wilks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kok, Adinda, Samuel Wilks, Sina Türeli, et al.. (2025). A vaccine central in A(H5) influenza antigenic space confers broad immunity. Nature. 647(8091). 1005–1013. 1 indexed citations
2.
Rössler, Annika, Antonia Netzl, Ninaad Lasrado, et al.. (2025). Nonhuman primate antigenic cartography of SARS-CoV-2. Cell Reports. 44(1). 115140–115140. 5 indexed citations
3.
Rössler, Annika, Antonia Netzl, Ludwig Knabl, et al.. (2024). Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera. npj Vaccines. 9(1). 85–85. 3 indexed citations
4.
Rössler, Annika, Antonia Netzl, Ludwig Knabl, et al.. (2023). Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography. Nature Communications. 14(1). 5224–5224. 18 indexed citations
5.
Kok, Adinda, Rachel D. Scheuer, Theo M. Bestebroer, et al.. (2023). Characterization of A/H7 influenza virus global antigenic diversity and key determinants in the hemagglutinin globular head mediating A/H7N9 antigenic evolution. mBio. 14(5). e0048823–e0048823. 4 indexed citations
6.
Ying, Baoling, Bradley Whitener, Laura A. VanBlargan, et al.. (2022). Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains. Science Translational Medicine. 14(630). eabm3302–eabm3302. 36 indexed citations
7.
Rössler, Annika, Antonia Netzl, Ludwig Knabl, et al.. (2022). BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants. Nature Communications. 13(1). 7701–7701. 42 indexed citations
8.
Gordon, David, Dimitar Sajkov, Yoshikazu Honda‐Okubo, et al.. (2016). Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant. Vaccine. 34(33). 3780–3786. 53 indexed citations
9.
Fonville, Judith M., Pieter L. A. Fraaij, Gerrie de Mutsert, et al.. (2015). Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection. The Journal of Infectious Diseases. 213(1). 31–38. 33 indexed citations
10.
Wilks, Samuel, Miranda de Graaf, Derek J. Smith, & David F. Burke. (2012). A review of influenza haemagglutinin receptor binding as it relates to pandemic properties. Vaccine. 30(29). 4369–4376. 49 indexed citations
11.
Bodewes, Rogier, Gerrie de Mutsert, Fiona van der Klis, et al.. (2011). Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands. Clinical and Vaccine Immunology. 18(3). 469–476. 135 indexed citations
12.
Wilks, Samuel. (1970). Unpublished papers of Thomas Hodgkin.. PubMed. 46(1). 67–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colleen Furey Breakdown of academic impact, for papers by Monique Ambrose Breakdown of academic impact, for papers by Kangchon Kim Breakdown of academic impact, for papers by Malet Aban Breakdown of academic impact, for papers by Svetlana Donina Breakdown of academic impact, for papers by Myeisha Paskel Breakdown of academic impact, for papers by Matthew Edmans Breakdown of academic impact, for papers by Wu-Tse Liu Breakdown of academic impact, for papers by Shahjahan Miah Breakdown of academic impact, for papers by Nazia Thakur
Rankless by CCL
2026